±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 567  |  »Ø¸´: 1
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

swlhlbr

гæ (³õÈëÎÄ̳)

[ÇóÖú] ´óÉñ°ï°ïæ~°ïÎÒ·­ÒëÒ»ÏÂÖÐÎÄÕªÒª£¨300×Ö£©~·Ç³£¸Ðл~

Ä¿µÄ£ºÍ¨¹ý½«ÃÅÕï·¢ÉúµÄÒ©Æ·²»Á¼·´Ó¦¼ÆÈëÃÅÕïµç×Ó²¡Àú£¬±£Ö¤ÃÅÕïËù·¢ÉúÒ©Æ·²»Á¼·´Ó¦µÄ¿É×·ËÝÐÔ£¬ÔÚ¼ÓÇ¿ÁÙ´²¸öÌ廯ÓÃÒ©°²È«µÄͬʱ´Ù½ø¶ÔÉÏÊÐÒ©Æ·µÄ°²È«ÖÊÁ¿¼à¿Ø£¬±£ÕϹã´ó»¼ÕßµÄÓÃÒ©°²È«¡£·½·¨£º³ÉÁ¢Æ·¹ÜȦ»î¶¯Ð¡×飬×ñÑ­PDCA³ÌÐò£¬»îÓÃÆ·¹ÜȦÆß´óÊÖ·¨£¬·ÖÎöÃÅÕïÒ©Æ·²»Á¼·´Ó¦ÄÑÒÔËÝÔ´µÄÔ­Òò£¬Ì½Ë÷¶Ô²ß£¬ÓèÒÔʵʩ²¢ÆÀ¹À»î¶¯Ð§¹û¡£ ½á¹û£º±È½Ï»î¶¯Ç°¡¢ºó¸÷ÏîÒ©Æ·²»Á¼·´Ó¦¿ÉËÝÔ´Ö¸±ê¾ùµÃµ½ÁËÃ÷ÏÔ¸ÄÉÆ£¬ÃÅÕïÒ©Æ·²»Á¼·´Ó¦¼ÆÈ벡ÀúÂÊÓɸÄÉÆÇ°31%ÉýÖÁ¸ÄÉÆºó90.1%£¬»î¶¯ºóÃÅÕïÍËÒ©µÇ¼Ç±íÈ·ÈÏÇ©ÃûÂÊ´ï87.2%£¬»î¶¯´ï±êÂÊΪ105.6%¡£½áÂÛ£º±¾´ÎÆ·¹ÜȦ»î¶¯ÓÐЧµÄÌá¸ßÁËÃÅÕïÒ©Æ·²»Á¼·´Ó¦¼ÆÈ벡ÀúµÄÖÊÁ¿£¬»¼Õß³ÐŵǩÃûÒ»¶¨³Ì¶ÈµÄ±£Ö¤ÁËÃÅÕïÒ©Æ·²»Á¼·´Ó¦µÄÕæÊµÐÔ£¬±£Ö¤ÁËÃÅÕïÒ©Æ·²»Á¼·´Ó¦µÄ¿ÉËÝÔ´ÐÔ£¬ÎªÒ©Æ·µÄÁÙ´²ºÏÀíʹÓÃÌṩÁËÒÀ¾Ý¡£
    ¹Ø¼ü´Ê£ºÒ©Æ·²»Á¼·´Ó¦£¬Æ·¹ÜȦ£¬ËÝÔ´

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Î人һÐÄÒ»Òë

¾èÖú¹ó±ö (ÖøÃûдÊÖ)


¡¾´ð°¸¡¿Ó¦Öú»ØÌû

É̼ÒÒѾ­Ö÷¶¯ÉùÃ÷´Ë»ØÌû¿ÉÄܺ¬ÓÐÐû´«ÄÚÈÝ
¡ï ¡ï ¡ï ¡ï ¡ï
swlhlbr: ½ð±Ò+5, ·­ÒëEPI+1, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, thanks 2016-04-15 14:05:09
Ä¿µÄ£ºÍ¨¹ý ½«ÃÅÕï ·¢ÉúµÄ Ò©Æ·²»Á¼·´Ó¦ ¼ÆÈë ÃÅÕï µç×Ó²¡Àú£¬±£Ö¤ÃÅÕï Ëù·¢Éú Ò©Æ·²»Á¼·´Ó¦µÄ ¿É×·ËÝÐÔ£¬ÔÚ¼ÓÇ¿ ÁÙ´² ¸öÌ廯 ÓÃÒ©°²È«µÄ ͬʱ ´Ù½ø ¶ÔÉÏÊÐÒ©Æ·µÄ °²È«ÖÊÁ¿¼à¿Ø£¬±£ÕÏ ¹ã´ó»¼ÕßµÄ ÓÃÒ©°²È«¡£·½·¨£º³ÉÁ¢ Æ·¹ÜȦ »î¶¯Ð¡×飬×ñÑ­ PDCA³ÌÐò£¬»îÓà Ʒ¹ÜȦ Æß´óÊÖ·¨£¬·ÖÎö ÃÅÕïÒ©Æ· ²»Á¼·´Ó¦ ÄÑÒÔËÝÔ´µÄ Ô­Òò£¬Ì½Ë÷ ¶Ô²ß£¬ÓèÒÔ ÊµÊ©²¢ÆÀ¹À »î¶¯Ð§¹û¡£ ½á¹û£º±È½Ï »î¶¯Ç°¡¢ºó ¸÷Ïî Ò©Æ·²»Á¼·´Ó¦ ¿É ËÝÔ´Ö¸±ê ¾ùµÃµ½ÁË Ã÷ÏÔ¸ÄÉÆ£¬ÃÅÕïÒ©Æ· ²»Á¼·´Ó¦ ¼ÆÈë ²¡ÀúÂÊ ÓɸÄÉÆÇ°31%Éý ÖÁ¸ÄÉÆºó 90.1%£¬»î¶¯ºó ÃÅÕïÍËÒ©µÇ¼Ç±í È·ÈÏÇ©ÃûÂÊ ´ï87.2%£¬»î¶¯´ï±êÂÊ Îª105.6%¡£½áÂÛ£º±¾´Î Æ·¹ÜȦ»î¶¯ ÓÐЧµÄ Ìá¸ßÁË ÃÅÕïÒ©Æ·²»Á¼·´Ó¦ ¼ÆÈ벡ÀúµÄ ÖÊÁ¿£¬»¼Õß ³ÐŵǩÃû Ò»¶¨³Ì¶ÈµÄ ±£Ö¤ÁË ÃÅÕïÒ©Æ·²»Á¼·´Ó¦µÄ ÕæÊµÐÔ£¬±£Ö¤ÁË ÃÅÕïÒ©Æ·²» Á¼·´Ó¦µÄ ¿ÉËÝÔ´ÐÔ£¬Îª Ò©Æ·µÄ ÁÙ´²ºÏÀí ʹÓÃÌṩÁËÒÀ¾Ý¡£
Purpose: Guarantee the traceability of adverse drug reactions occurred during outpatient treatment by recording them into electronic medical record(EMR), and enhance monitoring the safety and quality of drugs
on current market in the meantime of strengthening individual medication safety, so as to secure the medication safety for massive patients. Method: Establish activity groups of quality control circle, follow PDCA procedures and flexibly use the QC 7 basic tools, analyze the reason why adverse drug reactions can hardly be traced, explore countermeasures, implement activity and evaluate activity effect. Results: Through comparing the traceability indexes of adverse drug reactions before and after the implementation of activity, it shows that the traceability indexes have been improved, and the rate of successfully recording adverse drug reactions into EMR has been increased from 31% before improvement to 90.1% after improvement, in addition, the signature rate on drug withdrawal list after implementation of activity can reach 87.2%, and the rate of reaching the standard in activity reached 105.6%. Conclusion: The QCC activity effectively improved the quality of recording adverse drug reactions into EMR. Patient's commitment to signature on drug withdrawal list guarantees the authenticity and traceability of adverse drug reactions, providing basis for clinical rational drug use.

¹Ø¼ü´Ê£ºÒ©Æ·²»Á¼·´Ó¦£¬Æ·¹ÜȦ£¬ËÝÔ´
Keywords: Adverse Drug Reaction, Quality Control Circle; Traceability
2Â¥2016-04-15 13:46:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ swlhlbr µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸ ÄϾ©º½¿Õº½Ìì´óѧ £¬080500²ÄÁÏ¿ÆÑ§Ó빤³Ìѧ˶ +10 @taotao 2026-03-30 10/500 2026-04-05 17:57 by jj987
[¿¼ÑÐ] 346·ÖµÄÉúÎïÓëÒ½Ò©08600Çóµ÷¼Á +5 ³£ÓêÑôÉϰ¶ 2026-04-05 6/300 2026-04-05 13:42 by imissbao
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤363ÇóÍÆ¼ö +7 zh096 2026-04-04 7/350 2026-04-05 09:11 by İÇï26
[¿¼ÑÐ] ÄÐÉú£¬Ò»Ö¾Ô¸»¦9ÉúÎïѧ071000£¬³õÊÔ308Çóµ÷¼Á +3 Áõīī 2026-04-04 3/150 2026-04-05 08:26 by barlinike
[¿¼ÑÐ] 309·Ö085801Çóµ÷¼Á +11 MY_angel 2026-03-31 11/550 2026-04-04 19:11 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 325Çóµ÷¼Á +4 ´º·ç²»½èÒâ 2026-04-04 4/200 2026-04-04 14:46 by ÏæÅ©´¢ÄܲÄÁÏ
[¿¼ÑÐ] Çóµ÷¼Á +3 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-04 3/150 2026-04-04 12:19 by Éá¶øºóµÃ
[¿¼ÑÐ] ±¾9Ò»Ö¾Ô¸2 0854µÍ·Öר˶286Çóµ÷¼Á +9 âÖÖ111 2026-04-04 9/450 2026-04-04 11:01 by tangruihua
[¿¼ÑÐ] Çóµ÷¼Á +3 wos666 2026-04-03 3/150 2026-04-04 05:16 by gswylq
[¿¼ÑÐ] ×Ü·Ö328ÉúÎïÓëÒ½Ò©¿¼ÊýѧÇóµ÷¼Á +7 aaadim 2026-04-02 9/450 2026-04-03 22:53 by syh9288
[¿¼ÑÐ] 11408£¬284·Ö£¬¶þÕ½Õæ³ÏÇóµ÷¼Á +4 12.27 2026-04-02 4/200 2026-04-03 14:14 by dxiaoxin
[¿¼ÑÐ] 266Çóµ÷¼Á +3 08µçÆø¹¤³Ì 2026-04-03 3/150 2026-04-03 14:05 by 1753564080
[¿¼ÑÐ] ÍÁľ304Çóµ÷¼Á +4 ÍÃͻͻͻ£¬ 2026-04-02 5/250 2026-04-02 21:16 by ÍÃͻͻͻ£¬
[¿¼ÑÐ] 348Çóµ÷¼Á +11 zzzzyk123 2026-04-01 11/550 2026-04-02 16:52 by Wang200018
[¿¼ÑÐ] 314Çóµ÷¼Á +11 1xiaojun23 2026-03-31 12/600 2026-04-02 12:31 by 1xiaojun23
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á +9 Ë«ÂíβƦÀϰå2 2026-04-01 9/450 2026-04-02 12:14 by oooqiao
[¿¼ÑÐ] 272Çóµ÷¼Á£¬½ÓÊÜ¿çרҵµ÷¼Á£¡ +4 ÏÐÓ㬠2026-03-31 4/200 2026-04-02 11:18 by guyan1000
[¿¼ÑÐ] °²È«¹¤³Ì 285 Çóµ÷¼Á +3 Xinyu56 2026-04-01 4/200 2026-04-01 21:50 by ¾²¾²¾²¾²¾²¾²¾²¾
[¿¼ÑÐ] 08¹¤¿Æ275Çóµ÷¼Á£¬¿É¿ç¿¼¡£ +5 AaAa7420 2026-03-31 5/250 2026-04-01 15:21 by 159357hjz
[¿¼ÑÐ] ÎïÀíѧµ÷¼Á +4 СÑò36 2026-03-30 4/200 2026-03-31 16:16 by lishahe
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û